Background and objectives: Unraveling the mechanisms of a number of enzyme models has
allowed for the design of efficient chemical devices having the potential to be utilized as …

Parkinson patients have insufficient dopamine in specific regions of the brain, so attempts
have been made to replenish the deficiency in the dopamine. Dopamine itself doesn't cross …

Prodrugs or predrugs are inactive molecules which become active after in vivo conversion to
release the active parent drug. The prodrug's cleavage can be catalyzed by metabolic …

Prodrugs or predrugs are inactive molecules which become active after in vivo conversion to
release the active parent drug. The prodrug's cleavage can be catalyzed by metabolic …

Prodrugs or predrugs are inactive molecules which become active after in vivo conversion to
release the active parent drug. The prodrug's cleavage can be catalyzed by metabolic …

This review provides the reader a concise overview of the different biological barriers that
hinder the delivery of therapeutic agents through membranes, such as intestinal mucosa …

The classical approach for delivery of drugs into the central nervous system (CNS) is
associated with adverse effects and it has many limitations. Therefore, extensive efforts have …

Prodrug is pharmacologically inactive molecule of an active drug molecule that prior to exert
its pharmacological effect requires an enzymatic and/or chemical transformation to release …

Marketed antibacterial drugs suffer several problems, such as bitter taste and low stability
which lead to patient incompliance. Prodrug technology for solving such problems is …

Prodrug is a chemical devise in which the drug is covalently linked to a chemical moiety; this
linked moiety will temporarily affect the physicochemical properties of the drug for increasing …